Referrals

Primary care physicians and other healthcare providers refer patients to The Rogosin Institute for expert care in kidney disease and lipid disorders. Our physicians are dedicated to working collaboratively with you to manage your patients.  

To refer a patient to Rogosin, please call (212) 746-1566

Kidney Disease
Contact:
John Wang, MD
212-746-3097

Dialysis
Jeffrey Silberzweig, MD
212-746-1562

Polycystic Kidney Disease
Contact:
Stephanie Donahue, NP
212-746-1591

Transplant
Contact:
Transplant Coordinator
212-517-3099

Cholesterol/Lipid Disorders
Contact:
Bruce Gordon, M.D.
212-746-1554

Clinical Trials

The Rogosin Institute has been involved in basic and clinical research for over 45 years.  These efforts support the mission of Rogosin to bring the results of research to patients as quickly as possible and to provide the best care possible.  Basic research involves experiments and studies that occur in a laboratory setting.  Clinical research involves the participation of human volunteers to help answer questions about new treatments or new ways of using known treatments (drugs and/or procedures) for diseases.

For information contact:
BJ Sloan, Research Manager
212-702-9600

Publications (November 2007-January 2009)

1. Biological Control of Cancer
Asinia S, Belenkaya R, Conn B, Cordon-Cardo C, David E, Diehl C,
Gazda L, Gordon B, Jain K, Lawrence S, Levine D, Parker T, Qiu S, Rubin A,
Smith B, Stenzel K, Vinerean H,
Nature Oncoloy, acceptance , 2008

2. Commentary: Health and Economics in the Mississippi Delta: Problems, Opportunities
Smith BH.
J Health Hum Serv Adm. 2008 Summer;31(1)168-73.

3. Epidemiology of BK Virus in Renal Allograft Recipients: Identification of Steroid Maintenance Therapy and Rabbit Anti-Human Thymocyte Globulin Induction as Independent Risk Factors for BKV Replication
Dadhania D, Snopkowski C, Ding R, Muthukumar T, Chang C, Aull M, Lee J, Sharma VK, Kapu S, and Suthanthiran M.
Transplantation 2008 in press

4. Effect of electronic patient record use on mortality in End Stage Renal Disease, a model chronic disease: retrospective analysis of 9 years of prospectively collected data
Pollak VE, Lorch JA.
BMC Med Inform Decis Mak. 2007 Nov 28;7:38.

5. Evaluation of Two Immunoassays for Montoring Low Blood Levels of Tacrolimus
Amman BS, Parker TS, Levine DM
Therapeutic Drug Monitoring, Nov. 2008

6. Improved Glucose Regulation on a Low Carbohydrate Diet in Diabetic Rats Transplanted with Macroencapsulated Porcine Islets
Vinerean HV, Gazda LS, Hall RD, Rubin AL, Smith BH
Cell Transplant. 2008;17(5):567-75

7. Institutional Commitment and HIV/AIDS: Lessons from the first 3 years of the Lesotho-Boston University Collaboration
Babich L.P., Bicknell W.J., Culpepper L., Jack B.W., Phooko M.W., Smith B., Thahane T.T.
Global Public Health, October 2008; 3(4): 417-432

8. Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhod for Homozygous Familial Hypercholesterolemia
Hudgins L, Kleinman B, Scheuer A, White S, Gordon B.
The American Journal of Cardiology 2008.06.049

9. Novel Method for Genomic Analysis of PKD1 and PKD2 Mutations in Autosomal Dominant Polycystic Kidney Disease
Tan Y, Blumenfed J, Anghel R, Donahue S, Belenkaya R, Balina M, Parker T, Levine D, Leonard D, Rennert H
Human Mutation 0, 1-10, 2008

10. Pretransplant Genetic Testing of Live Kidney Donoars at Risk for Autosomal Dominant Polycystic Kidney Disease
Blumenfeld J
Transplantation. Volume 87, Number 1, January 15, 2009

11. Rituximab Treatment of Fibrillary Glomerulonephritis
Collins M, Navaneethan S, Chung M, Sloand J, Goldman B, Appel G, Rovin B
American Journal of Kidney Diseases, Vol 52, No 6(December), 2008:pp 1158-1162

12. The Importance of Iron in Long-Term Survival of Maintenance Hemodialysis Patients Treated with Epoetin-Alpha and i Intravenous iron:analysis of 9.5 years of prospectively collected data
Pollak Victor, Lorch Jonathan, Shukla Rakesh, Satwah Supriya.
In Review, BMC Nephrology

13. US Healthcare on the Edge: A Prescription for Cure
Lorch J, Pollak V
Not reviewed. Health Care Policy and Marketplace Review, August 30, 2008

Fellowship Program

The Nephrology Fellowship Program, under the direction of Phyllis August, M.D., in Weill Cornell’s Department of Medicine’s Division of Nephrology, continues to utilize Rogosin Kidney Center’s facilities for training.  The basic program is two years although Fellows may elect to spend a third year in research.  This program offers Fellows a comprehensive educational experience in all areas including renal transplantation.

For further information contact:

Fran Gillen, Administrator
Renal Fellowship Program
Division of Nephrology & Hypertension
New York Presbyterian Hospital
Weill Cornell Medical College
450 East 69th Street, 1st Floor
New York, NY 10021
212-746-2165